arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Programme

Saturday 25 Jun

Scientific programme Post-ASCO

09:00 - 11:00 Session 1

Chairs: M. Dicato and J. Vermorken

09:00

Immunology

Bart Neyns, VUB

09:25

Gastrointestinal cancer

Eric Van Cutsem, UZ Leuven

09:50

Lung cancer

Veerle Surmont, UZ Gent

10:15

Urogenital cancer

Bertrand Tombal, UCL

10:40

Session: information from Pharma (majors sponsors only)

11:00

Break

11:30 - 13:15 Session 2

Chairs: M. Dicato and J. Vermorken

11:30

Arificial Intelligence in Oncology: what will the future look like

Alexander T. Pearson

I am a quantitative scientist, medical oncologist, and co-director of the head/neck cancer program at the University of Chicago. My training included an MD as well as a PhD in statistics from the University of Rochester, and clinical residency and fellowship with postdoctoral studies in applied mathematics and cancer stem cell biology at the University of Michigan. My laboratory at the University of Chicago has a combined focus on integrating cancer biology techniques into mathematical modeling frameworks as well as developing artificial intelligence and machine learning-based cancer biomarkers. My goal as a practicing physician is to maintain a cutting-edge, data-driven, research-intensive clinical practice with clinical trial protocols evaluating scientific questions across the full natural history of head/neck cancers.

12:00

Gynaecological cancer

Frédéric Kridelka, CHU de Liège

12:25

Head and neck cancer

Jean-Pascal Machiels, UC Louvain

12:50

Breast cancer

Martine Piccart, Institut Jules Bordet

13:15

Lunch

Friday 24 Jun

Satellite symposium

19:00

Registration & warm buffet

Scientific programme

Moderator: Prof. H. Wildiers (UZ Leuven)

20:00

Welcome

Prof. H. Wildiers (UZ Leuven)

20:05

Impact of advances in mBC on curing in eBC

Prof. A. Awada (Jules Bordet Institute)

20:30

How does therapy escalation improve the outcome of high risk patients in BC

Dr. D. Taylor (CHU UCL Namur)

21:00

Break

Part 2

21:10

5 years of clinical experience with CDK 4/6i: achievements and issues in patient management

Prof. S. Altintas (UZA)

21:40

Panel discussion

Moderator: Prof. Wildiers

22:15

Closure